Ferenci P - Search Results

1

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.

Scherzer TM, Hofer H, Staettermayer AF, Rutter K, Beinhardt S, Steindl-Munda P, Kerschner H, Kessler HH, Ferenci P. Scherzer TM, et al. Among authors: ferenci p. J Hepatol. 2011 May;54(5):866-71. doi: 10.1016/j.jhep.2010.08.024. Epub 2011 Jan 14. J Hepatol. 2011. PMID: 21145807 Clinical Trial.

2

Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha.

Peck-Radosavljevic M, Wichlas M, Homoncik-Kraml M, Kreil A, Hofer H, Jessner W, Gangl A, Ferenci P. Peck-Radosavljevic M, et al. Among authors: ferenci p. Gastroenterology. 2002 Jul;123(1):141-51. doi: 10.1053/gast.2002.34175. Gastroenterology. 2002. PMID: 12105843

3

Subclinical impairment of brain function in chronic hepatitis C infection.

Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P. Kramer L, et al. Among authors: ferenci p. J Hepatol. 2002 Sep;37(3):349-54. doi: 10.1016/s0168-8278(02)00172-1. J Hepatol. 2002. PMID: 12175630

4

Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.

Jessner W, Der-Petrossian M, Christiansen L, Maier H, Steindl-Munda P, Gangl A, Ferenci P. Jessner W, et al. Among authors: ferenci p. Hepatology. 2002 Nov;36(5):1301-2. doi: 10.1053/jhep.2002.35072. Hepatology. 2002. PMID: 12395349 No abstract available.

5

Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a.

Hofer H, Bankl HC, Wrba F, Steindl-Munda P, Peck-Radosavljevic M, Osterreicher C, Mueller C, Gangl A, Ferenci P. Hofer H, et al. Among authors: ferenci p. Am J Gastroenterol. 2002 Nov;97(11):2880-5. doi: 10.1111/j.1572-0241.2002.07056.x. Am J Gastroenterol. 2002. PMID: 12425563

6

Hepatitis C viral dynamics: basic concept and clinical significance.

Jessner W, Watkins-Riedel T, Formann E, Steindl-Munda P, Ferenci P. Jessner W, et al. Among authors: ferenci p. J Clin Virol. 2002 Dec;25 Suppl 3:S31-9. doi: 10.1016/s1386-6532(02)00194-4. J Clin Virol. 2002. PMID: 12467775 Review.

7

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load.

Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, Gangl A, Ferenci P. Hofer H, et al. Among authors: ferenci p. Hepatology. 2003 Jan;37(1):60-4. doi: 10.1053/jhep.2003.50019. Hepatology. 2003. PMID: 12500189

8

Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.

Steindl-Munda P, Ferenci P, Brunner H, Nachbaur K, Datz C, Gschwantler M, Hofer H, Stauber R, Hackl F, Jessner W, Rosenbeiger M, Gangl A, Vogel W; Austrian Hepatitis Study Group. Steindl-Munda P, et al. Among authors: ferenci p. Liver Int. 2003 Aug;23(4):269-75. doi: 10.1034/j.1600-0676.2003.00838.x. Liver Int. 2003. PMID: 12895267 Clinical Trial.

9

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.

Ferenci P. Ferenci P. J Antimicrob Chemother. 2004 Jan;53(1):15-8. doi: 10.1093/jac/dkh015. Epub 2003 Nov 25. J Antimicrob Chemother. 2004. PMID: 14645325 Review.

10

Protease inhibitors for treatment of chronic hepatitis C--a new target for the magic bullet identified.

Ferenci P. Ferenci P. J Hepatol. 2004 Jan;40(1):184-6. doi: 10.1016/j.jhep.2003.10.015. J Hepatol. 2004. PMID: 14672633 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters